Literature DB >> 304293

Relationship of various QRS indices to SGOT levels in acute anterior myocardial infarction.

S W Rabkin.   

Abstract

In 52 first myocardial infarction which were anterior in location, several QRS indices derived from measurements of precordial QRS complexes using their correlation with highest recorded value of serum glutamic oxaloacetic transaminase (SGOT). The sum of R amplitudes in V1 to V6 inclusive (3r V1-6) was preferred over indices which included measurements of Q amplitude or duration because it was simpler to calculate and most frequently showed the best significant correlation with SGOT both in the presence or absence of radiologic evidence of pulmonary congestion. Furthermore calculation of change from normal values of precordial R amplitudes did no improve the correlation. Thus 3r V1-6 perhaps as a reflection of amount of loss of myocardial muscle mass is a quantitative ECG approach which correlates with severity of myocardial infarction and should receive more attention in evaluation of infarct size in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304293

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  2 in total

1.  Clinical implications of QRS duration and QT peak prolongation in patients with suspected coronary disease referred for elective cardiac catheterization.

Authors:  M Nadeem Attar; Kenneth Wong; David G Groves; Nick Newall; David R Ramsdale; Roger K Moore
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-04       Impact factor: 1.468

2.  The effects of QRS duration and pacing sites on the acute hemodynamic changes during right ventricular pacing.

Authors:  Young Joon Hong; Bo Ra Yang; Doo Seon Sim; Sang Yup Lim; Sang Hyun Lee; Ji Hyun Lim; Han Gyun Kim; Ok Young Park; Ju Han Kim; Weon Kim; Nam Ho Kim; Young Keun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.